Business Context and Reporting Period
This Form 8-K filing by Accuray Incorporated (Accuray) covers the date of August 3, 2011. The report details a material definitive agreement entered into on this date regarding an existing strategic alliance.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a contractual amendment rather than financial performance data.
Material Changes
Accuray amended its Strategic Alliance Agreement with Siemens Aktiengesellschaft (Siemens), originally dated June 8, 2010. The amendment extends the termination rights for both parties related to Accuray's acquisition of TomoTherapy Incorporated until December 31, 2011. This extension allows both companies to evaluate the impact of the acquisition on their existing arrangements.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future performance, or a discussion of general risks. The primary contingency noted is the evaluation period for the TomoTherapy acquisition's impact on the Siemens alliance, with a decision deadline of December 31, 2011.
Key Facts for Investor Verification
- Accuray and Siemens extended the termination window for their Strategic Alliance Agreement to December 31, 2011.
- The extension is specifically tied to the evaluation of Accuray's acquisition of TomoTherapy Incorporated.
- No financial results or operational metrics are disclosed in this specific filing.